Role of non-NMDA receptors in vasopressin and oxytocin release from rat hypothalamo-neurohypophysial explants

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 280, Issue 2 49-2, 2001, Pages

  Morsette, Delmore J ^a   Sidorowicz, Hanna ^a   Sladek, Celia D ^a,b  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b The Chicago Medical College   (United States)

Author keywords

Aminopropionic acid; Glutamate; Kainate; N methyl D aspartate; Osmolality; Supraoptic nucleus

Indexed keywords

4 METHYLGLUTAMIC ACID; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; CYCLOTHIAZIDE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; KAINIC ACID; KAINIC ACID RECEPTOR; OXYTOCIN; VASOPRESSIN;

ANIMAL EXPERIMENT; ARTICLE; AUTOCRINE EFFECT; CONTROLLED STUDY; EXPLANT; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; NONHUMAN; OSMORECEPTOR; OSMOREGULATION; OXYTOCIN RELEASE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; RECEPTOR DOWN REGULATION; SUPRAOPTIC NUCLEUS; VASOPRESSIN RELEASE;

EID: 0035010610     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.2001.280.2.r313     Document Type: Article

References (48)

1. Al-Ghoul WM, Meeker RB, and Greenwood RS. Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in vasopressin and oxytocin neuroendocrine cells. Mol Brain Res 44: 262-272, 1997.
2. Armstrong WE and Stern JE. Electrophysiological and morphological characteristics of neurons in perinuclear zone of supraoptic nucleus. J Nearophysiol 78: 2427-2437, 1997.
3. Bicknell RJ, Brown D, Chapman C, Hancock PD, and Leng G. Reversible fatigue of stimulus-secretion coupling in the rat neurohypophysis. J Physiol (Lond) 348: 601-613, 1984.
4. Bisset GW and Fairhall KM. Release of vasopressin and oxytocin by excitatory amino acid agonists and the effect of antagonists on release by muscarine and hypertonic saline, in the rat in vivo. Br J Pharmacol 117: 309-314, 1996.
5. Boudaba C, Schrader LA, and Tasker JG. Physiological evidence for local excitatory synaptic circuits in the rat hypothalamus. J Neurol 77: 3396-3400, 1997.
6. Boudaba C, Szabo K, and Tasker JG. Physiological mapping of local inhibitory inputs to the hypothalamic paraventricular nucleus. J Neurosci 16: 7151-7160, 1996.
7. Bourque CW, Oliet SHR, and Richard D. Osmoreceptors, osmoreception, and osmoregulation. Front Neuroendocrinol 15: 231-274, 1994.
8. Chakfe Y and Bourque CW. Excitatory peptides and osmotic pressure modulate mechanosensitive cation channels in concert. Nat Neurosci 3: 572-579, 2000.
9. Donovan SD, Beg A, Gunther JM, and Twyman RE. The methylglutamate, SYM 2081, is a potent and highly selective agonist at kainate receptors. J Pharmacol Exp Ther 285: 539-545, 1998.
10. Ginsberg SD, Price DL, Blackstone CD, Huganir RL, and Martin LJ. The AMPA glutamate receptor GluR3 is enriched in oxytocinergic magnocellular neurons and is localized at synapses. Neuroscience 65: 563-575, 1995.
11. Gribkoff VK and Dudek FE. The effects of the excitatory amino acid antagonist kynurenic acid on synaptic transmission to supraoptic neuroendocrine cells. Brain Res 442: 152-156, 1988.
12. Hattori Y, Shibuya I, Tanaka K, Kabashima N, Ueta Y, and Yamashita H. Ionotropic and metabotropic glutamate receptor agonist-induced [Ca2+]i increase in isolated rat supraoptic neurons. J Neuroendocrinol 10: 383-389, 1998.
13. Hollman M and Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci 17: 31-108, 1994.
14. Hu B and Bourque CW. NMDA receptor-mediated rhythmic bursting activity in rat supraoptic nucleus neurones in vitro. J Physiol (Lond) 458: 667-687, 1992.
15. Hussy N, Boissin-Agasse L, Richard P, and Desarmenien MG. NMDA receptor properties in rat supraoptic magnocellular neurons: characterization and postnatal development. Eur J Neurosci 9: 1439-1449, 1997.
16. Lind RW, Swanson LW, and Ganten D. Organization of angiotensin II-immunoreactive cells and fibers in the rat central nervous system. An immunohistochemical study. Neuroendocrinology 40: 2-24, 1985.
17. Martin D, Blackstone CD, Levey AI, Huganir RL, and Price DL. AMPA glutamate receptor subunits are differentially distributed in rat brain. Neuroscience 53: 327-358, 1993.
18. Meeker RB, Swanson DJ, Greenwood RS, and Hayward JN. Quantitative mapping of glutamate presynaptic terminals in the supraoptic nucleus and surrounding hypothalmus. Brain Res 600: 112-122, 1992.
19. Meeker RB, Swanson DJ, and Hayward JN. Light and electron microscopic localization of glutamate immunoreactivity in the supraoptic nucleus of the rat hypothalamus. Neuroscience 33: 157-167, 1989.
20. Monyer H, Burnasherv N, Laurie DJ, Sakmann B, and Seeburg PH. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12: 529-540, 1994.
21. Nissen R, Hu B, and Renaud LP. N-methyl-D-aspartate receptor antagonist ketamine selectively attenuates spontaneous phasic activity of supraoptic vasopressin neurons in vivo. Neuroscience 59: 115-120, 1994.
22. Nissen R, Hu B, and Renaud LP. Regulation of spontaneous phasic firing of rat supraoptic vasopressin neurones in vivo by glutamate receptors. J Physiol (Lond) 484: 415-424, 1995.
23. Nowak L, Bregostovski P, Ascher P, Herbert A, and Prochiantz A. Magnesium gates glutamate-active channels in mouse central neurones. Nature 307: 462-465, 1984.
24. Partin KM, Bowie D, and Mayer ML. Structural determinants of allosteric regulation in alternatively spliced AMPA receptors. Neuron 14: 833-843, 1995.
25. Partin KM, Patneau DK, Winters CA, Mayer ML, and Buonanno A. Selective modulation of desensitization at AMPA versus kainate receptors by cyclothiazide and concanavalin A. Neuron 11: 1069-1082, 1993.
26. Pelletier JC, Hesson DP, Jones KA, and Costa AM. Substituted 1,2-dihydrophthalazines: potent, selective, and noncompetitive inhibitors of the AMPA receptor. J Med Chem 39: 343-346, 1996.
27. Petralia RS, Wang YX, and Wenthold RJ. Histological and ultrastructural localization of the kainate receptor subunits, KA2 and GluR6/7, in the rat nervous system using selective antipeptide antibodies. J Comp Neural 349: 85-110, 1994.
28. Petralia RS and Wenthold RJ. Light and electron immunocytochemical localization of AMPA-selective glutamate receptors in the rat brain. J Comp Neurol 318: 329-354, 1992.
29. Richard D and Bourque CW. Synaptic activation of rat supraoptic neurons by osmotic stimulation of the organum vasculosum lamina terminalis. Neuroendocrinology 55: 609-611, 1992.
30. Richardson CM and Wakerly JB. Glutamate excitation of oxytocin neurones in vitro involves predominantly non-NMDA receptors. Brain Res 767: 158-161, 1997.
31. Sato K, Kiyama H, and Tohyama M. The differential expression patterns of messenger RNAs encoding non-N-methyl-D-aspartate glutamate receptor subunits (GluR1-4) in the rat brain. Neuroscience 52: 515-539, 1993.
32. Sato K, Mick G, Kiyama H, and Tohyama M. Expression patterns of a glutamate-binding protein in the rat central nervous system: comparison with N-methyl-D-aspartate receptor subunit 1 in rat. Neuroscience 64: 459-475, 1995.
33. Sladek CD. Antidiuretic hormone:synthesis and release. In: Handbook of Physiology: The Endocrine System, edited by Fray JCS. Bethesda, MD: Am Physiol Soc, 2000, sec 7, vol III, p. 436-495.
34. Sladek CD and Armstrong WE. GABA antagonists stimulate vasopressin release from organ-cultured hypothalamo-neurohypophyseal explants. Endocrinology 120: 1576-1580, 1987.
35. Sladek CD, Badre SE, Morsette DJ, and Sidorowicz HE. Role of non-NMDA receptors in osmotic and glutamate stimulation of vasopressin release: effect of rapid receptor desensitization. J Neuroendocrinol 10: 897-903, 1998.
36. Sladek CD and Joynt RJ. Cholinergic involvement in osmotic control of vasopressin release by the organ cultured rat hypothalamo-neurohypophyseal system. Endocrinology 105: 367-371, 1979.
37. Sladek CD and Joynt RJ. Role of angiotensin in the osmotic control of vasopressin release by the organ-cultured rat hypothalamo-neurohypophyseal system. Endocrinology 106: 173-178, 1980.
38. Sladek CD, Swenson KL, Kapoor R, and Sidorowicz HE. The role of steroid hormones in the regulation of vasopressin and oxytocin release and mRNA expression in hypothalamo-neurohypophysial explants from the rat. Exp Physiol 85S: 171S-177S, 2000.
39. Stern JE, Galarreta M, Foehring RC, Hestrin S, and Armstrong WE. Differences in the properties of ionotropic glutamate synaptic currents in oxytocin and vasopressin neuroendocrine neurons. J Neurosci 19: 3367-3375, 1999.
40. Swenson KL, Badre SE, Morsette DJ, and Sladek CD. N-methyl-D-aspartic (NMDA) stimulation of vasopressin release: role in osmotic regulation and modulation by gonadal steroids. J Neuroendocrinol 10: 679-685, 1998.
41. Swenson KL and Sladek CD. Gonadal steroid modulation of vasopressin secretion in response to osmotic stimulation. Endocrinology 138: 2089-2097, 1997.
42. Trussell LO and Fischbach GD. Glutamate receptor desensitization and its role in synaptic transmission. Neuron 3: 209-218, 1998.
43. Van den Pol, AN, Herman-Borgmeyer I, Hofer M, Ghosh P, and Heinemann S. Ionotropic glutamate-receptor gene expression in hypothalamus: localization of AMPA, kainate, and NMDA receptor RNA with in situ hybridization. J Comp Neurol 343: 428-444, 1994.
44. Van den Pol, AN, Waurin JP, and Dudek FE. Glutamate, the dominant excitatory transmitter in neuroendocrine regulation. Science 250: 1276-1278, 1990.
45. Verney EB. The antidiuretic hormone and the factors which determine its release. Proc R Soc Lond B Biol Sci 135: 25-106, 1947.
46. Wafford KA, Bain CJ, Le BB, Whiting PJ, and Kemp JA. Preferential co-assembly of recombinant NMDA receptors composed of three different subunits. Neuroreport 4: 1347-1349, 1993.
47. Yagil C and Sladek CD. Effect of extended exposure to hypertonicity on vasopressin mRNA content in hypothalamo-neurohypophyseal explants. Endocrinology 127: 1428-1435, 1990.
48. Yang CR, Senatorov VV, and Renaud LP. Organum vasculosum lamina terminalis-evoked post-synaptic responses in rat supraoptic neurones in vitro. J Physiol (Lond) 477: 59-74, 1994.